Delivery Order SPE2DB24D1107-SPE2DB24FZEE2
Award Date 4/30/24
Potential Completion Date 5/21/24
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,740.49, is for PROQUAD VIALS with a delivery order contract type and firm fixed price pricing. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PROQUAD VIALS to the Defense Logistics Agency (DLA). The $2,686.44 firm fixed-price delivery order has a completion date of July 10, 2025 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The $2,740.49 firm fixed-price delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle to supply a wide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with an ultimate completion date of April 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $1,570.54, has a completion date of July 31, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC enables the DLA to...
- This federal contract award, valued at $1,670.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a completion date of July 30, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,012.70 firm fixed-price delivery order is for PROQUAD VIALS, with a completion date of June 12, 2025. The contract is not set aside and represents an order under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides global pharmaceutical support to...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,601.99 firm fixed-price delivery order is for the provision of 4,564,891,320 doses of the PROQUAD vaccine product. The contract has a completion date of July 3, 2024 and does not utilize a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a...
- This federal contract award, valued at $15,705.40, was issued to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a firm fixed-price Delivery Order for the supply of PROQUAD VIALS, with a period of performance through July 3, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,141.08 and a completion date of July 5, 2024. It is a Firm Fixed Price Delivery Order contract, which means the price will not change regardless of Amerisourcebergen's costs. The contract does not have a set-aside designation, indicating it was competed on a full and open basis....